1.56
price down icon7.14%   -0.12
after-market Handel nachbörslich: 1.56
loading

Finanzdaten der Lipocine Inc-Aktie (LPCN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
59.22%
0.1901
0.1194 1.1454 0.1146 0.6228
Operating Expenses
23.60%
3.0323
3.9689 3.6612 3.4756 3.0272
Depreciation and Amortization
1.12%
0.0146
0.0148 0.015 0.0141 0.0161
Operating Income/Loss
26.17%
-2.8422
-3.8495 -2.5158 -3.361 -2.4044
Nonoperating Income/Loss
23.81%
0.2199
0.1776 0.1457 0.1742 0.1986
Income/Loss From Continuing Operations Before Tax
28.58%
-2.6224
-3.6719 -2.3701 -3.1868 -2.2057
Income Tax Expense/Benefit
0.0002
- - - -
Net Income/Loss
28.58%
-2.6226
-3.6719 -2.3701 -3.1868 -2.2057
Basic Average Shares
20.93%
8.217
6.795 0.0774 5.4131 5.352
Diluted Average Shares
20.93%
8.217
6.795 0.3368 5.4131 5.352
Basic Earnings Per Share
40.74%
-0.32
-0.54 - -0.59 -0.41
Diluted Earnings Per Share
40.74%
-0.32
-0.54 - -0.59 -0.41
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Kapitalisierung:     |  Volumen (24h):